EUR 26.78
(2.53%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 45.27 Million EUR | -35.07% |
2022 | 69.77 Million EUR | 25.14% |
2021 | 55.75 Million EUR | 28.65% |
2020 | 43.33 Million EUR | 25.49% |
2019 | 34.53 Million EUR | 51.31% |
2018 | 22.82 Million EUR | 14.79% |
2017 | 19.88 Million EUR | 19.54% |
2016 | 16.63 Million EUR | 11.29% |
2015 | 14.94 Million EUR | 37.09% |
2014 | 10.9 Million EUR | -43.26% |
2013 | 19.21 Million EUR | 3.8% |
2012 | 18.51 Million EUR | -7.09% |
2011 | 19.92 Million EUR | 0.76% |
2010 | 19.77 Million EUR | -11.52% |
2009 | 22.34 Million EUR | -29.71% |
2008 | 31.79 Million EUR | 0.0% |
2005 | 7.81 Million EUR | -5.65% |
2004 | 8.28 Million EUR | -59.82% |
2003 | 20.62 Million EUR | -24.05% |
2002 | 27.15 Million EUR | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q3 | 10.1 Million EUR | -4.72% |
2024 Q1 | 16.6 Million EUR | 12.93% |
2024 Q2 | 10.6 Million EUR | -36.14% |
2023 Q2 | 15.9 Million EUR | -3.05% |
2023 Q1 | 16.4 Million EUR | -18.29% |
2023 FY | 45.3 Million EUR | -35.07% |
2023 Q4 | 14.7 Million EUR | -5.77% |
2023 Q3 | 15.6 Million EUR | -1.89% |
2022 FY | 69.77 Million EUR | 25.14% |
2022 Q2 | 17.4 Million EUR | 18.37% |
2022 Q1 | 14.7 Million EUR | -12.79% |
2022 Q4 | 20.07 Million EUR | 13.39% |
2022 Q3 | 17.7 Million EUR | 1.72% |
2021 Q2 | 13.1 Million EUR | 9.17% |
2021 Q4 | 16.85 Million EUR | 21.26% |
2021 FY | 55.75 Million EUR | 28.65% |
2021 Q1 | 12 Million EUR | -12.02% |
2021 Q3 | 13.9 Million EUR | 6.11% |
2020 Q4 | 13.63 Million EUR | 19.64% |
2020 Q3 | 11.4 Million EUR | 16.33% |
2020 Q2 | 9.8 Million EUR | 15.29% |
2020 Q1 | 8.5 Million EUR | -20.09% |
2020 FY | 43.33 Million EUR | 25.49% |
2019 FY | 34.53 Million EUR | 51.31% |
2019 Q1 | 6.3 Million EUR | -1.96% |
2019 Q2 | 7.5 Million EUR | 19.05% |
2019 Q3 | 10 Million EUR | 33.33% |
2019 Q4 | 10.63 Million EUR | 6.37% |
2018 Q2 | 5.7 Million EUR | 7.55% |
2018 Q3 | 5.4 Million EUR | -5.26% |
2018 Q1 | 5.3 Million EUR | -6.77% |
2018 Q4 | 6.42 Million EUR | 19.0% |
2018 FY | 22.82 Million EUR | 14.79% |
2017 Q3 | 4.7 Million EUR | -6.0% |
2017 FY | 19.88 Million EUR | 19.54% |
2017 Q4 | 5.68 Million EUR | 20.96% |
2017 Q2 | 5 Million EUR | 13.64% |
2017 Q1 | 4.4 Million EUR | -7.06% |
2016 Q3 | 4 Million EUR | -2.44% |
2016 Q1 | 3.9 Million EUR | -10.26% |
2016 FY | 16.63 Million EUR | 11.29% |
2016 Q2 | 4.1 Million EUR | 5.13% |
2016 Q4 | 4.73 Million EUR | 18.35% |
2015 Q2 | 3.7 Million EUR | 8.82% |
2015 Q3 | 3.5 Million EUR | -5.41% |
2015 Q4 | 4.34 Million EUR | 24.17% |
2015 FY | 14.94 Million EUR | 37.09% |
2015 Q1 | 3.4 Million EUR | 1025.83% |
2014 Q1 | 4.9 Million EUR | 13.61% |
2014 FY | 10.9 Million EUR | -43.26% |
2014 Q4 | 302 Thousand EUR | -90.85% |
2014 Q2 | 5 Million EUR | 2.04% |
2014 Q3 | 3.3 Million EUR | -34.0% |
2013 Q1 | 5 Million EUR | 8.46% |
2013 FY | 19.21 Million EUR | 3.8% |
2013 Q2 | 5.1 Million EUR | 2.0% |
2013 Q4 | 4.31 Million EUR | -10.15% |
2013 Q3 | 4.8 Million EUR | -5.88% |
2012 FY | 18.51 Million EUR | -7.09% |
2012 Q1 | 5.1 Million EUR | 8.01% |
2012 Q2 | 4.2 Million EUR | -17.65% |
2012 Q3 | 4.6 Million EUR | 9.52% |
2012 Q4 | 4.61 Million EUR | 0.22% |
2011 Q2 | 5.2 Million EUR | -7.14% |
2011 Q3 | 5 Million EUR | -3.85% |
2011 FY | 19.92 Million EUR | 0.76% |
2011 Q4 | 4.72 Million EUR | -5.56% |
2011 Q1 | 5.6 Million EUR | -6.21% |
2010 Q1 | 4.9 Million EUR | -2.89% |
2010 FY | 19.77 Million EUR | -11.52% |
2010 Q2 | 4.7 Million EUR | -4.08% |
2010 Q4 | 5.97 Million EUR | 45.63% |
2010 Q3 | 4.1 Million EUR | -12.77% |
2009 Q4 | 5.04 Million EUR | -1.06% |
2009 Q2 | 5.5 Million EUR | -19.12% |
2009 Q1 | 6.8 Million EUR | 0.0% |
2009 FY | 22.34 Million EUR | -29.71% |
2009 Q3 | 5.1 Million EUR | -7.27% |
2008 FY | 31.79 Million EUR | 0.0% |
2005 FY | 7.81 Million EUR | -5.65% |
2004 FY | 8.28 Million EUR | -59.82% |
2003 FY | 20.62 Million EUR | -24.05% |
2002 FY | 27.15 Million EUR | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
BBS-Bioactive Bone Substitutes Oyj | -3619.00 EUR | 1251163.83% |
Modulight Oyj | 1.06 Million EUR | -4159.266% |
Nexstim Plc | 2.31 Million EUR | -1858.359% |